Journal: Cell Death & Disease
Article Title: RETRACTED ARTICLE: FABP4 contributes to renal interstitial fibrosis via mediating inflammation and lipid metabolism
doi: 10.1038/s41419-019-1610-5
Figure Lengend Snippet: a The protein levels of FABP4, PPARγ, p65, and ICAM based on immunefluorescence staining (400× magnification) and western blotting assay after treatment by FABP4 inhibitor in NRK-52E and NRK-49F cells. b The protein levels of EHHADH, ACOX1, SCP-2, CPT1, ACADM, and ACADL in NRK-52E and NRK-49F cells treated by FABP4 inhibitor. c The protein levels of α-SMA and COL1A based on immunofluorescence assay (400× magnification), and the mRNA levels of α-SMA, COL1A1, and COL3A1 in NRK-52E and NRK-49F cells after treatment by FABP4 inhibitor in NRK-52E and NRK-49F cells. d The lipid droplets based on Oil O Red staining (400× magnification) and the levels of TC, TG, and FFAs in NRK-52E and NRK-49F cells after FABP4 inhibitor treatment. Data are presented as the mean ± SD ( n = 3). ** p < 0.01 control groups compared with LPS groups, ## p < 0.01 and # p < 0.05 LPS groups compared with FABP4 inhibitor groups
Article Snippet: Mouse and Rat FABP4 ELISA Kits were purchased from Boster Biological Technology Co., Ltd. (California, USA).
Techniques: Staining, Western Blot, Immunofluorescence